GLSI
Greenwich LifeSciences, Inc.
13.12
+
0.78
6.32%
0 x 0.00
0 x 0.00
bid
ask
0 @ 04:00 PM
11.90-1.22 (9.30%)
Bearish
20
Bullish
39
sentiment
12.30
day range
13.29
7.77
52 week range
20.32
Prev Close12.34
Open12.75
Low12.30
High13.29
Volume27.89K
Avg. Volume52.20K
Market Cap168.96M
Inst. Own4.86%
Beta3.19
Short Ratio4.98
Div & Yield0.00 /
EPS-0.69
P/E0.00
1yr Target36.00
50day MA15.31
200day MA11.04
CNQ.TO
Canadian Natural Resources Limited
106.52
04:00 PM
+
0.84
0.79%
G.TO
Augusta Gold Corp.
0.96
03:59 PM
-
0.07
6.80%
AAA.AX
BetaShares Australian High Interest Cash ETF
50.25
02:10 AM
+
0.01
0.02%
ACC.NS
ACC Limited
2533.05
05:59 AM
-
46.55
1.80%
600690.SS
Haier Smart Home Co., Ltd.
28.35
03:00 AM
-
0.08
0.28%
0700.HK
Tencent Holdings Limited
348.40
04:08 AM
+
9.00
2.65%
1101.TW
Taiwan Cement Corp.
31.80
01:30 AM
-
0.20
0.62%
20MICRONS.NS
20 Microns Limited
162.85
05:59 AM
+
5.90
3.76%
Day Gain | ||
Gain | ||
Market Val | ||
Costs | ||
Cash | ||
Portfolio | ||
Realized | ||
Dividend |
News
...
TOPS, SURG: The Top 5 Short Squeeze Stocks This Week | investorplace.com • |
GLSI, APRN: The Top 5 Short Squeeze Stocks to Watch This Week | investorplace.com • |
NRBO, FAZE: The Top 5 Short Squeeze Stocks to Watch This Week | investorplace.com • |
ATHX, PETS: The Top 5 Short Squeeze Stocks to Watch This Week | investorplace.com • |
Greenwich LifeSciences: Persevering CEO And Interesting Data | seekingalpha.com • |
7 Short-Term Stocks to Buy for a Quick Profit | investorplace.com • |
Profile
...
Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which is in Phase III clinical trial to prevent breast cancer recurrences in patients who have previously undergone surgery. The company was formerly known as Norwell, Inc. and changed its name to Greenwich LifeSciences, Inc. in March 2018. Greenwich LifeSciences, Inc. was incorporated in 2006 and is headquartered in Stafford, Texas.
Earning
...
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-05-27 | 2024-03 | -0.2 | N/A | N/A | N/A |
2024-04-15 | 2023-12 | 0 | -0.21 | N/A | N/A |
2023-10-19 | 2023-09 | -0.22 | -0.19 | 0.03 | 13.64% |
2023-10-19 | 2023-09 | -0.22 | N/A | N/A | N/A |
2023-08-21 | 2023-06 | -0.23 | N/A | N/A | N/A |
2023-08-21 | 2023-06 | -0.23 | -0.13 | 0.1 | 43.48% |
Upgrade / Downgrade
...
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-04-09 | HC Wainwright & Co. | Upgrade | Buy | |
2021-08-31 | HC Wainwright & Co. | Upgrade | Buy | |
2021-01-26 | Aegis Capital | Upgrade | Buy | |
2021-01-25 | Aegis Capital | Upgrade | Buy |
Insider Holder
...
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2022-04-24 | DAUGHERTY FRANK JOSEPH | Officer and Director | 90.12K | Purchase |
2022-01-20 | HALLOCK KENNETH | Director | 397.30K | Purchase |
2021-12-13 | MCWILLIAMS DAVID B | Director | 620.30K | Purchase |
2020-09-28 | PATEL KINNARY | Beneficial Owner of more than 10% of a Class of Security | 0.00 | Conversion of Exercise of derivative security |
2024-03-31 | PATEL SNEHAL | Chief Executive Officer | 5.35M | Purchase |
2020-11-19 | ROTHE ERIC | Director | 313.23K | Purchase |
Institution Ownership
...
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Group Inc | 282.21K | 2.72M | 2.20% |
2023-06-29 | Renaissance Technologies, LLC | 79.20K | 763.88K | 0.62% |
2023-06-29 | Ameriprise Financial, Inc. | 68.19K | 657.71K | 0.53% |
2023-06-29 | Blackrock Inc. | 57.58K | 555.31K | 0.45% |
2023-06-29 | Geode Capital Management, LLC | 39.93K | 385.15K | 0.31% |
2023-06-29 | Millennium Management Llc | 35.35K | 340.93K | 0.28% |
Fund Ownership
...
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 215.14K | 2.08M | 1.67% |
2023-06-29 | Vanguard Extended Market Index Fund | 54.75K | 528.08K | 0.43% |
2023-05-30 | Fidelity Extended Market Index Fund | 20.93K | 227.91K | 0.16% |
2023-08-30 | iShares Micro Cap ETF | 14.14K | 129.67K | 0.11% |
2023-05-30 | Fidelity NASDAQ Composite Index Fund | 7.22K | 78.63K | 0.06% |
2023-06-29 | Vanguard Balanced Index Fund | 6.06K | 58.49K | 0.05% |
This topic has been deleted. Only users with topic management privileges can see it.
-
No way will I sell
This is just an Indicator on how much the stock is valued -
It is going to end well when they get fda approval this summer
-
Back up to 100
-
This will be 200 this July
-
$snre is another late stage cancer play
-
Selling before power hour is just plain dumb
-
Ah will be nice
-
Wait for the good news tomorrow
Don’t sell -
-
Low float!!!
She can hit 100 -
It was1:00 when it took off to 156 last time
-
Last time she took off it was around 1:00
-
All in ! Let’s fight breast cancer
-
-
5B market cap potential at 500M. $GLSI a 10x right here. Bought in to keep my eye on it. Love titties
-
Buy IDEX ITS it’s going to big run ️ guys
-
TOPS, SURG: The Top 5 Short Squeeze Stocks This Week
investorplace.com • -
GLSI, APRN: The Top 5 Short Squeeze Stocks to Watch This Week
investorplace.com • -
NRBO, FAZE: The Top 5 Short Squeeze Stocks to Watch This Week
investorplace.com • -
ATHX, PETS: The Top 5 Short Squeeze Stocks to Watch This Week
investorplace.com • -
Greenwich LifeSciences: Persevering CEO And Interesting Data
seekingalpha.com • -
7 Short-Term Stocks to Buy for a Quick Profit
investorplace.com • -
Why Is Greenwich Lifesciences (GLSI) Stock Up Today?
investorplace.com • -
Greenwich LifeSciences: A First Look
seekingalpha.com • -
Follow the Insiders and Buy the Dip in These 3 Stocks
investorplace.com • -
Recession Fears are Creating a Golden Opportunity for Biotech Stocks
investorplace.com • -
Greenwich LifeSciences to Present at 2022 BIO CEO & Investor Conference
businesswire.com • -
3 Stocks Insiders Are Buying on Market Turbulence
investorplace.com • -
The Moonshot Investor: The Insider Track Strategy
investorplace.com • -
A Controversial Moonshot Stock Just Got a Lot More Interesting
investorplace.com • -
3 Stocks Insiders Are Snapping Up. Do They Know Something We Don't?
investorplace.com • -
Greenwich LifeSciences to Present at the Cantor Global Healthcare Conference
businesswire.com • -
Greenwich LifeSciences Provides Updates on Recent and Upcoming Developments
businesswire.com • -
Greenwich LifeSciences Set to Join Russell 2000® Index
businesswire.com • -
What's Going On With GLSI Stock And PSMT Stock Today?
benzinga.com • -
Greenwich LifeSciences Is Both a Sound Investment and a Feel-Good Buy
investorplace.com • -
Greenwich LifeSciences CEO to be Interviewed Live on Benzinga's Power Hour
businesswire.com • -
GLSI Stock: Why Greenwich LifeSciences Is Skyrocketing Today
investorplace.com • -
Greenwich LifeSciences' LD Micro Presentation Replay Now Available
businesswire.com • -
Shares of Startup Biotechs Soar on Cancer Study Results
gurufocus.com • -
This Was the Top-Performing IPO in 2020
fool.com • -
Greenwich LifeSciences to Ring Nasdaq Opening Bell on December 28
businesswire.com • -
GLSI Stock: Why Greenwich LifeSciences Is Up 2,000% Today
investorplace.com • -
IPO Update: Greenwich LifeSciences Moves Ahead With IPO
seekingalpha.com • -
Greenwich LifeSciences Files For U.S. IPO
seekingalpha.com •